For example, one BRD4 inhibitor originally designed for cancer treatment, JQ1, was shown to be beneficial in mouse models of ischemic stroke, myocardial infarction, LPS-induced lung inflammation, and cisplatin-induced nephrotoxicity [34,54,55,56,57]. This evidence concerns the gene BRD4 and myocardial infarction.